J3247 HCPCS code: Injection, secukinumab, intravenous, 1 mg
J3247 is the HCPCS Level II code for injection, secukinumab, intravenous, 1 mg. In 2024 Medicare paid an average of $13.70 per service for J3247 across 2,636,558 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 1000 per day on DME suppliers. In 2024, about 1,363 clinicians billed Medicare for J3247 for 2,717 beneficiaries; Florida, Texas, California accounted for 30% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2024-07-01 |
| Last action effective | 2024-07-01 |
Who bills J3247 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 1,363 |
| Medicare beneficiaries | 2,717 |
| States with claims | 36 |
| Share of services in top 3 states (Florida, Texas, California) | 30% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J3247, 2024–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2024 | 2,636,558 | 2,717 | $17.19 | $13.70 |
States with the most J3247 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 329,750 | $13.75 |
| Texas | 249,037 | $13.76 |
| California | 198,111 | $13.75 |
| Pennsylvania | 145,002 | $13.73 |
| North Carolina | 107,776 | $13.53 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 1000 | CMS Policy |
| outpatient hospital claims | 1000 | CMS Policy |
| practitioner claims | 1000 | CMS Policy |
What changed for J3247
- 2024-07-01: J3247 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J3247?
J3247 is the HCPCS Level II code for injection, secukinumab, intravenous, 1 mg. Short descriptor: "Inj secukinumab intrav 1mg".
How much does Medicare pay for J3247?
In 2024, the average Medicare payment was $13.70 per service (average allowed $17.19).
Does Medicare cover J3247?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J3247 can be billed per day?
1000 on DME suppliers; 1000 on outpatient hospital claims; 1000 on practitioner claims (NCCI medically unlikely edits).
Related J32 codes
- J3230 — Injection, chlorpromazine hcl, up to 50 mg
- J3240 — Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial
- J3241 — Injection, teprotumumab-trbw, 10 mg
- J3243 — Injection, tigecycline, 1 mg
- J3244 — Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg
- J3245 — Injection, tildrakizumab, 1 mg
- J3246 — Injection, tirofiban hcl, 0.25 mg
- J3250 — Injection, trimethobenzamide hcl, up to 200 mg
- J3260 — Injection, tobramycin sulfate, up to 80 mg
- J3262 — Injection, tocilizumab, 1 mg
- J3263 — Injection, toripalimab-tpzi, 1 mg
- J3265 — Injection, torsemide, 10 mg/ml
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J3247
- Watch J3247 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J3247
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.